Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
About the GECP
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Español
English
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
About the GECP
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
About the GECP
Publish
Authors Instructions
Online submission
ES
EN
TOC Alert
Volume 2 – Number 2
2026
>
Volume 2 - Number 2
A diagnostic challenge after neoadjuvant chemoimmunotherapy: looking beyond tumor recurrence
2026
>
Volume 2 - Number 2
Between evidence and fear of recurrence: decision-making in adjuvant treatment of a ypT1aN0 case after neoadjuvant therapy. Are we ready to forgot treatment?
2026
>
Volume 2 - Number 2
Synchronous small-cell lung cancer and metastatic gastric gastrointestinal stromal tumor: concurrent chemo-radiotherapy, consolidation immunotherapy, and imatinib
2026
>
Volume 2 - Number 2
Lambert-Eaton syndrome associated with small cell lung cancer
2026
>
Volume 2 - Number 2
Reactivation of an anti-Hu paraneoplastic syndrome in a patient with small-cell lung cancer treated with immunotherapy: a diagnostic and therapeutic challenge
2026
>
Volume 2 - Number 2
The use of immune checkpoint inhibitors in the treatment of advanced non-small cell lung cancer in a bilateral lung transplant recipient